INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "TESTOSTERONE AND DIFLUOROMETHYLORNITHINE COMBINATION THERAPY FOR PROSTATE CANCER"

GENEVA, April 30 -- THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2024/028823) for "TESTOSTERONE AND DIFLUOROMETHYLORNITHINE COMBINATION THERAPY FOR PROSTATE CANCER" on May 10, 2024. With publication no. WO/2025/085110, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DENMEADE, Samuel R. (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Maryland 21218), SENA, Laura A. (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Ma...